Trials / Completed
CompletedNCT00565006
A Study to Investigate the Influence of MK0859 on Blood Pressure (MK-0859-012)(COMPLETED)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 45 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This study will investigate the influence of MK0859 on ambulatory blood pressure, and how safe and tolerable MK0859 is on the subjects This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0859 |
Timeline
- Start date
- 2006-07-01
- Primary completion
- 2006-09-01
- Completion
- 2006-09-01
- First posted
- 2007-11-29
- Last updated
- 2015-02-27
Source: ClinicalTrials.gov record NCT00565006. Inclusion in this directory is not an endorsement.